ERIKA HANNIGAN: Open Payments
NPI 1215582150 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 12 payments from 9 companies in 2025. Trend: 2023 $804 · 2024 $820 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: VYEPTI, REXULTI, TRINTELLIX, XELJANZ, TRELEGY ELLIPTA, VOQUEZNA, MOUNJARO, Korlym.
Industry payments across OH — which companies pay providers there.
